Trial intelligence / Profile preview

Comparative Study of Efficacy and Safety of Roselle Tablets and Amlodipine in Patients with Mild Hypertension

TCTR20250624010Phase 3Not yet recruiting

Sponsor
National Research Council of Thailand
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of roselle, amlodipine in hypertension (HTN), sponsored by National Research Council of Thailand. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

roselleamlodipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on TCTR20250624010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250624010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call